Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Jan 11;23:40. doi: 10.1186/s12885-023-10518-w

Correction: Carnitine palmitoyl transferase 1 A is a novel diagnostic and predictive biomarker for breast cancer

Zheqiong Tan 1,✉,#, Yaru Zou 2,#, Man Zhu 1, Zhenzhao Luo 1, Tangwei Wu 1, Chao Zheng 1, Aqing Xie 1, Hui Wang 1, Shiqiang Fang 1, Shuiyi Liu 1,3,4, Yong Li 5,6, Zhongxin Lu 1,
PMCID: PMC9832673  PMID: 36631771

Correction: BMC Cancer 21, 409 (2021)

https://doi.org/10.1186/s12885-021-08134-7

Following publication of the original article [1], the authors reported an error in the funding section. The funding number for the National Science Foundation of China was incorrect. The funding statement should read as follows:

This research was funded by National Science Foundation of China (81802652), Research Fund of Hubei Province Health Bureau (WJ2015MB144) and Research Fund of Wuhan Public Health Bureau (WX15A12 and WX18Y11). The funders had no role in the design of the study, data collection, analysis, interpretation of data, or in writing the manuscript.

Footnotes

Zheqiong Tan and Yaru Zou contributed equally to this work.

Contributor Information

Zheqiong Tan, Email: ztan9@jhmi.edu.

Zhongxin Lu, Email: lzx71@yahoo.com.

Reference

  • 1.Tan Z, Zou Y, Zhu M, et al. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 2021;21:409. doi: 10.1186/s12885-021-08134-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES